SE8204810L - Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a - Google Patents

Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a

Info

Publication number
SE8204810L
SE8204810L SE8204810D SE8204810D SE8204810L SE 8204810 L SE8204810 L SE 8204810L SE 8204810 D SE8204810 D SE 8204810D SE 8204810 D SE8204810 D SE 8204810D SE 8204810 L SE8204810 L SE 8204810L
Authority
SE
Sweden
Prior art keywords
procedure
dna molecule
hybrid dna
transformed microorganism
make protein
Prior art date
Application number
SE8204810D
Other languages
English (en)
Swedish (sv)
Other versions
SE8204810D0 (sv
Inventor
S Lofdahl
M Uhlen
M Lindberg
Original Assignee
Pharmacia Fine Chemicals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Fine Chemicals Ab filed Critical Pharmacia Fine Chemicals Ab
Publication of SE8204810D0 publication Critical patent/SE8204810D0/xx
Publication of SE8204810L publication Critical patent/SE8204810L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
SE8204810D 1982-08-23 1982-08-23 Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a SE8204810L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8204810A SE462046C (sv) 1982-08-23 1982-08-23 Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma

Publications (2)

Publication Number Publication Date
SE8204810D0 SE8204810D0 (sv) 1982-08-23
SE8204810L true SE8204810L (sv) 1984-02-24

Family

ID=20347592

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8204810D SE8204810L (sv) 1982-08-23 1982-08-23 Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a
SE8204810A SE462046C (sv) 1982-08-23 1982-08-23 Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8204810A SE462046C (sv) 1982-08-23 1982-08-23 Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma

Country Status (4)

Country Link
JP (1) JPH0755153B2 (esLanguage)
DE (1) DE3390105T1 (esLanguage)
SE (2) SE8204810L (esLanguage)
WO (1) WO1984000773A1 (esLanguage)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
CA1311429C (en) * 1983-07-06 1992-12-15 Vasantha Nagarajan Vector for polypeptides in bacilli
US4801537A (en) * 1984-06-08 1989-01-31 Genex Corporation Vector for expression of polypeptides in bacilli
JPH07108224B2 (ja) * 1985-11-07 1995-11-22 重三 鵜高 バチルス・ブレビスを用いる遺伝子の発現方法
EP0317641B1 (en) * 1987-05-29 1993-03-17 Sagami Chemical Research Center Fused protein containing lymphotoxin
US5243040A (en) * 1987-11-20 1993-09-07 Creative Biomolecules DNA encoding a protein which enables selective removal of immune complexes
JP2566325B2 (ja) * 1987-11-20 1996-12-25 クリエイティブ・バイオマリキュールズ・インコーポレーテッド 免疫複合体の選択的除去
US5084398A (en) * 1987-11-20 1992-01-28 Creative Biomolecules Selective removal of immune complexes
ES2058538T3 (es) * 1988-07-22 1994-11-01 Imre Corp Compuestos de proteina a purificados y procedimiento para su preparacion.
WO1993002107A1 (fr) * 1991-07-25 1993-02-04 Oriental Yeast Co., Ltd. Proteine artificielle de combinaison avec les immunoglobulines
GB9823071D0 (en) * 1998-10-21 1998-12-16 Affibody Technology Ab A method
SE0301936D0 (sv) * 2003-06-30 2003-06-30 Affibody Ab New polypeptide
EP1718386A1 (en) 2004-02-27 2006-11-08 GE Healthcare Bio-Sciences AB A process for the purification of antibodies
SE0400501D0 (sv) 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
PL1827691T3 (pl) 2004-10-21 2017-07-31 Ge Healthcare Bioprocess R&D Ab Matryca chromatograficzna
US20080220968A1 (en) 2005-07-05 2008-09-11 Ge Healthcare Bio-Sciences Ab [1, 2, 4] Triazolo [1, 5-A] Pyrimidine Derivatives as Chromatographic Adsorbent for the Selective Adsorption of Igg
CA2666053C (en) 2006-12-06 2011-03-29 Repligen Corporation Nucleic acids encoding recombinant protein a
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG162687A1 (en) 2008-12-24 2010-07-29 Millipore Corp Caustic stable chromatography ligands
SG10201604554WA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
BR112015005937A2 (pt) 2012-09-17 2017-07-04 Grace W R & Co meios e dispositivos cromatográficos
PL3094390T3 (pl) 2014-01-16 2021-12-06 W.R. Grace & Co. - Conn. Nośniki do chromatografii powinowactwa i urządzenia do chromatografii

Also Published As

Publication number Publication date
DE3390105C2 (esLanguage) 1993-01-07
SE462046C (sv) 1998-04-27
JPH0755153B2 (ja) 1995-06-14
JPS59501693A (ja) 1984-10-11
SE8204810D0 (sv) 1982-08-23
SE462046B (sv) 1990-04-30
DE3390105T1 (de) 1984-10-18
WO1984000773A1 (en) 1984-03-01

Similar Documents

Publication Publication Date Title
SE8204810L (sv) Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a
FI840090L (fi) Hybridproteiner.
NO157480C (no) Hybridmodus hornantenne.
FI863612A7 (fi) Kreditarrangemang foer ett kommunikationsnaet.
ATE118528T1 (de) Brennstoffabrikate.
FI854020L (fi) Stol.
FI860654A7 (fi) Laodabildande hoernelement och en laoda innehaollande ett saodant.
FI862653L (fi) Bensinblandning.
FI831420L (fi) Tricykliska foereningar, deras framstaellning, anvaendning och mellanprodukter
FI862378A7 (fi) Elastomerbelagt loephjul och kaernanordning foer en form foer densamma.
FI882746A0 (fi) Hybridprotein c och foerfarande foer dess framstaellning.
FI864305A0 (fi) Stol utan ryggstoed.
FI875324L (fi) Hybridproteiner.
FI863704L (fi) Foerbaettringar betraeffande viraliska isolater och deras anvaendning.
FI872921A0 (fi) Ett mikrobhaerlett vaexters tillvaext befraemjande aemne och utbytet oekande aemne.
FI863137L (fi) Dispergerbara mjukgoeringsmedel foer tyger.
DE3586765D1 (de) Immunogenische hav-peptide.
IT8620740A0 (it) Collettore di carburante.
FI853654A0 (fi) Ett reglersystem foer ventilationen i en pappersmaskins torkkaopa.
DE3672622D1 (de) Ordner.
FI864345A7 (fi) Flermotoranlaeggning omfattande ett flertal turboladdade foerbraenningsmotorer.
NO164406C (no) Stablebart brett.
FI881268L (fi) Hybridserpiner och dessa kodande dna:n.
FI864329A7 (fi) 1-metyl-15 -alkylandrosta-1,4-dien -3,17-dioner foerfaranden foer deras framstaellning och laekemedelspreparat innehaollande dessa.
DE3669053D1 (de) Beschleunigungsaufnehmer.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8204810-9